Skip to main content
Erschienen in: Sleep and Breathing 1/2019

14.06.2018 | Sleep Breathing Physiology and Disorders • Original Article

Obstructive sleep apnea and the effect of CPAP treatment on ischemia-modified albumin levels: a multi effect size meta-analysis with diagnostic test accuracy

verfasst von: Seshadri Reddy Varikasuvu, Naveen Dutt, Dibakar Sahu

Erschienen in: Sleep and Breathing | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

A close association of oxidative stress (OS) and ischemia-modified albumin (IMA) with obstructive sleep apnea (OSA) has been reported in the literature, but the results on IMA are ambiguous. We conducted a meta-analysis to evaluate the association of IMA with OSA and the effect of continuous positive airway pressure (CPAP) therapy on IMA in patients with OSA.

Methods

Relevant studies were identified by searching PubMed and other databases in addition to manual searching of cross-references. Using random-effects model, the standardized mean differences (SMDs), pooled correlation coefficients and summary of diagnostic test accuracies were obtained with 95% confidence intervals (CIs). The meta-regression, sub-group and sensitivity analyses were performed to explore heterogeneity. The presence of publication bias was tested using funnel plot analysis followed by Begg’s and Egger’s tests for statistical signidicance.

Results

This meta-analysis finally included nine studies. When comparing with non-OSA controls, the OSA patients showed a significantly increased circulatory IMA levels (SMD = 1.15, p = 0.0001). And, this increase is even more pronounced in severe-OSA group as compared to mild-moderate OSA patients (SMD = 076, p = 0.0006). A decrease in post-CPAP treatment IMA was observed when compared with that of baseline values. Meta-analysis of correlations showed significant associations of IMA with polysomnographic parameters. The pooled diagnostic odds ratio and area under curve were 19.58 and 0.888 (Q* = 0.819), respectively. There was no evidence of publication bias for the association of IMA with OSA.

Conclusion

This meta-analysis suggests that OSA is associated with significantly increased IMA levels which may indicate OS, ischemia and subclinical cardiovascular risk. In the diagnostic test accuracy meta-analysis, IMA showed good accuracy for OSA detection. However, further studies are required to establish its clinical utility.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165:1217–1239CrossRefPubMed Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165:1217–1239CrossRefPubMed
2.
Zurück zum Zitat Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, Vollenweider P, Tafti M, Haba-Rubio J (2015) Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 3:310–318CrossRefPubMedPubMedCentral Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, Vollenweider P, Tafti M, Haba-Rubio J (2015) Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 3:310–318CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Eisele HJ, Markart P, Schulz R (2015) Obstructive sleep apnea, oxidative stress, and cardiovascular disease: evidence from human studies. Oxidative Med Cell Longev 2015:608438CrossRef Eisele HJ, Markart P, Schulz R (2015) Obstructive sleep apnea, oxidative stress, and cardiovascular disease: evidence from human studies. Oxidative Med Cell Longev 2015:608438CrossRef
5.
Zurück zum Zitat Bourdon E, Blache D (2001) The importance of proteins in defense against oxidation. Antioxid Redox Signal 3:293–311CrossRefPubMed Bourdon E, Blache D (2001) The importance of proteins in defense against oxidation. Antioxid Redox Signal 3:293–311CrossRefPubMed
6.
Zurück zum Zitat Faure P, Tamisier R, Baguet JP, Favier A, Halimi S, Levy P, Pepin JL (2008) Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome. Eur Respir J 31:1046–1053CrossRefPubMed Faure P, Tamisier R, Baguet JP, Favier A, Halimi S, Levy P, Pepin JL (2008) Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome. Eur Respir J 31:1046–1053CrossRefPubMed
7.
Zurück zum Zitat Bar-Or D, Lau E, Winkler JV (2000) A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary report. J Emerg Med 19:311–315CrossRefPubMed Bar-Or D, Lau E, Winkler JV (2000) A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary report. J Emerg Med 19:311–315CrossRefPubMed
8.
Zurück zum Zitat Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF (2006) Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 92:113–114CrossRefPubMedPubMedCentral Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF (2006) Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 92:113–114CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Seneş M, Kazan N, Coşkun O et al (2007) Oxidative and nitrosative stress in acute ischaemic stroke. Ann Clin Biochem 44:43–47CrossRef Seneş M, Kazan N, Coşkun O et al (2007) Oxidative and nitrosative stress in acute ischaemic stroke. Ann Clin Biochem 44:43–47CrossRef
10.
Zurück zum Zitat Turedi S, Gunduz A, Mentese A, Karahan SC, Yilmaz SE, Eroglu O, Nuhoglu I, Turan I, Topbas M (2007) Value of ischemia-modified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med 25:770–773CrossRefPubMed Turedi S, Gunduz A, Mentese A, Karahan SC, Yilmaz SE, Eroglu O, Nuhoglu I, Turan I, Topbas M (2007) Value of ischemia-modified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med 25:770–773CrossRefPubMed
11.
Zurück zum Zitat Dogan D, Ocal N, Aydogan M, Tasci C, Arslan Y, Tapan S, Yetkin S, Bilgic H (2016) Assessment of the role of serum ischemia-modified albumin in obstructive sleep apnea in comparison with interleukin-6. Postgrad Med 128:603–608CrossRefPubMed Dogan D, Ocal N, Aydogan M, Tasci C, Arslan Y, Tapan S, Yetkin S, Bilgic H (2016) Assessment of the role of serum ischemia-modified albumin in obstructive sleep apnea in comparison with interleukin-6. Postgrad Med 128:603–608CrossRefPubMed
13.
Zurück zum Zitat Karamanli H, Kiyici A, Arik B, Efe D, Akgedik R (2016) Influence of obstructive sleep apnea on ischemia-modified albumin levels and carotid intima-media thickness. J Investig Med 64:1035–1041CrossRefPubMed Karamanli H, Kiyici A, Arik B, Efe D, Akgedik R (2016) Influence of obstructive sleep apnea on ischemia-modified albumin levels and carotid intima-media thickness. J Investig Med 64:1035–1041CrossRefPubMed
14.
Zurück zum Zitat Ozben S, Huseyinoglu N, Hanikoglu F, Guvenc TS, Yildirim BZ, Cort A, Ozdem S, Ozben T (2014) Advanced oxidation protein products and ischaemia-modified albumin in obstructive sleep apnea. Eur J Clin Investig 44:1045–1052CrossRef Ozben S, Huseyinoglu N, Hanikoglu F, Guvenc TS, Yildirim BZ, Cort A, Ozdem S, Ozben T (2014) Advanced oxidation protein products and ischaemia-modified albumin in obstructive sleep apnea. Eur J Clin Investig 44:1045–1052CrossRef
15.
Zurück zum Zitat Öztuna F, Gözaçan H, Kiriş G et al (2013) Effect of nasal continuous positive airway pressure on global right ventricular myocardial performance in patients with obstructive sleep apnea syndrome. Turk J Med Sci 43:393–399 Öztuna F, Gözaçan H, Kiriş G et al (2013) Effect of nasal continuous positive airway pressure on global right ventricular myocardial performance in patients with obstructive sleep apnea syndrome. Turk J Med Sci 43:393–399
16.
Zurück zum Zitat Sunnetcioglu A, Asker S, Alp HH, Gunbatar H (2016) Increased asymmetric dimethylarginine and ischemia-modified albumin levels in obstructive sleep apnea. Respir Care 61:1038–1043CrossRefPubMed Sunnetcioglu A, Asker S, Alp HH, Gunbatar H (2016) Increased asymmetric dimethylarginine and ischemia-modified albumin levels in obstructive sleep apnea. Respir Care 61:1038–1043CrossRefPubMed
17.
Zurück zum Zitat Uygur F, Tanriverdi H, Can M et al (2016) The impact of obstructive sleep apnoea and nasal continuous positive airway pressure on circulating ischaemia-modified albumin concentrations. Mediat Inflamm 2016:8907314CrossRef Uygur F, Tanriverdi H, Can M et al (2016) The impact of obstructive sleep apnoea and nasal continuous positive airway pressure on circulating ischaemia-modified albumin concentrations. Mediat Inflamm 2016:8907314CrossRef
18.
19.
Zurück zum Zitat Yang LX, Ma SG, Liu H, Xu W (2013) Influence of obstructive sleep apnea on serum butyrylcholinesterase activity and ischemia-modified albumin levels. Clinics (Sao Paulo) 68:968–973CrossRef Yang LX, Ma SG, Liu H, Xu W (2013) Influence of obstructive sleep apnea on serum butyrylcholinesterase activity and ischemia-modified albumin levels. Clinics (Sao Paulo) 68:968–973CrossRef
20.
Zurück zum Zitat Hukins CA (2006) Obstructive sleep apnea—management update. Neuropsychiatr Dis Treat 3:309–326CrossRef Hukins CA (2006) Obstructive sleep apnea—management update. Neuropsychiatr Dis Treat 3:309–326CrossRef
21.
Zurück zum Zitat Barceló A, Barbé F, de la Peña M et al (2006) Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 27:756–760CrossRefPubMed Barceló A, Barbé F, de la Peña M et al (2006) Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 27:756–760CrossRefPubMed
22.
Zurück zum Zitat Li W, Ma D, Liu M, Liu H, Feng S, Hao Z, Wu B, Zhang S (2008) Association between metabolic syndrome and risk of stroke: a meta-analysis of cohort studies. Cerebrovasc Dis 25:539–547CrossRefPubMed Li W, Ma D, Liu M, Liu H, Feng S, Hao Z, Wu B, Zhang S (2008) Association between metabolic syndrome and risk of stroke: a meta-analysis of cohort studies. Cerebrovasc Dis 25:539–547CrossRefPubMed
23.
Zurück zum Zitat Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM, QUADAS-2 Group (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536CrossRef Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM, QUADAS-2 Group (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536CrossRef
24.
Zurück zum Zitat He Y, Chen R, Wang J, Pan W, Sun Y, Han F, Wang Q, Liu C (2016) Neurocognitive impairment is correlated with oxidative stress in patients with moderate-to-severe obstructive sleep apnea hypopnea syndrome. Respir Med 120:25–30CrossRefPubMed He Y, Chen R, Wang J, Pan W, Sun Y, Han F, Wang Q, Liu C (2016) Neurocognitive impairment is correlated with oxidative stress in patients with moderate-to-severe obstructive sleep apnea hypopnea syndrome. Respir Med 120:25–30CrossRefPubMed
25.
Zurück zum Zitat Paz Y, Mar HL, Hazen SL, Tracy RP et al (2016) Effect of continuous positive airway pressure on cardiovascular biomarkers: the sleep apnea stress randomized controlled trial. Chest 150:80–90CrossRef Paz Y, Mar HL, Hazen SL, Tracy RP et al (2016) Effect of continuous positive airway pressure on cardiovascular biomarkers: the sleep apnea stress randomized controlled trial. Chest 150:80–90CrossRef
26.
Zurück zum Zitat Lavie L, Lavie P (2009) Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 33:1467–1484CrossRefPubMed Lavie L, Lavie P (2009) Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 33:1467–1484CrossRefPubMed
27.
Zurück zum Zitat Alonso-Fernández A, García-Río F, Arias MA et al (2009) Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax 64:581–586CrossRefPubMed Alonso-Fernández A, García-Río F, Arias MA et al (2009) Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax 64:581–586CrossRefPubMed
28.
Zurück zum Zitat Paruthi S, Rosen CL, Wang R, Weng J, Marcus CL, Chervin RD, Stanley JJ, Katz ES, Amin R, Redline S (2015) End-tidal carbon dioxide measurement during pediatric polysomnography: signal quality, association with apnea severity, and prediction of neurobehavioral outcomes. Sleep 38:1719–1726CrossRefPubMedPubMedCentral Paruthi S, Rosen CL, Wang R, Weng J, Marcus CL, Chervin RD, Stanley JJ, Katz ES, Amin R, Redline S (2015) End-tidal carbon dioxide measurement during pediatric polysomnography: signal quality, association with apnea severity, and prediction of neurobehavioral outcomes. Sleep 38:1719–1726CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Adly AAM, ElSherif NHK, Ismail EAR et al (2017) Ischemia-modified albumin as a marker of vascular dysfunction and subclinical atherosclerosis in β-thalassemia major. Redox Rep 22:430–438CrossRefPubMed Adly AAM, ElSherif NHK, Ismail EAR et al (2017) Ischemia-modified albumin as a marker of vascular dysfunction and subclinical atherosclerosis in β-thalassemia major. Redox Rep 22:430–438CrossRefPubMed
30.
Zurück zum Zitat Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC (2004) Role of “ischemia modified albumin”, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 21:29–34CrossRefPubMedPubMedCentral Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC (2004) Role of “ischemia modified albumin”, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 21:29–34CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Baysal T, Alp H, Koç N, Atabek ME, Eklioğlu BS, Karaarslan S (2012) Serum ischemia-modified albumin level and its association with cardiovascular risk factors in obese children and adolescents. J Pediatr Endocrinol Metab 25:935–944CrossRefPubMed Baysal T, Alp H, Koç N, Atabek ME, Eklioğlu BS, Karaarslan S (2012) Serum ischemia-modified albumin level and its association with cardiovascular risk factors in obese children and adolescents. J Pediatr Endocrinol Metab 25:935–944CrossRefPubMed
32.
Zurück zum Zitat Reddy VS, Suchitra MM, Pradeep V et al (2015) Ischemia-modified albumin levels in overt and subclinical hypothyroidism. J Endocrinol Investig 38:885–890CrossRef Reddy VS, Suchitra MM, Pradeep V et al (2015) Ischemia-modified albumin levels in overt and subclinical hypothyroidism. J Endocrinol Investig 38:885–890CrossRef
33.
Zurück zum Zitat Reddy VS, Agrawal P, Sethi S, Gupta N, Garg R, Madaan H, Kumar V (2015) Associations of FPG, A1C and disease duration with protein markers of oxidative damage and antioxidative defense in type 2 diabetes and diabetic retinopathy. Eye (Lond) 29:1585–1593CrossRef Reddy VS, Agrawal P, Sethi S, Gupta N, Garg R, Madaan H, Kumar V (2015) Associations of FPG, A1C and disease duration with protein markers of oxidative damage and antioxidative defense in type 2 diabetes and diabetic retinopathy. Eye (Lond) 29:1585–1593CrossRef
34.
Zurück zum Zitat Ukinc K, Eminagaoglu S, Ersoz HO, Erem C, Karahan C, Hacihasanoglu AB, Kocak M (2009) A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin. Endocrine 36:425–432CrossRefPubMed Ukinc K, Eminagaoglu S, Ersoz HO, Erem C, Karahan C, Hacihasanoglu AB, Kocak M (2009) A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin. Endocrine 36:425–432CrossRefPubMed
35.
Zurück zum Zitat Reddy VS, Sethi S, Agrawal P, Gupta N, Garg R (2015) Ischemia modified albumin (IMA) and albumin adjusted-IMA (AAIMA) as biomarkers for diabetic retinopathy. Nepal J Ophthalmol 7:117–123CrossRefPubMed Reddy VS, Sethi S, Agrawal P, Gupta N, Garg R (2015) Ischemia modified albumin (IMA) and albumin adjusted-IMA (AAIMA) as biomarkers for diabetic retinopathy. Nepal J Ophthalmol 7:117–123CrossRefPubMed
37.
Zurück zum Zitat Cifçi N, Uyar M, Elbek O et al (2010) Impact of CPAP treatment on cardiac biomarkers and pro-BNP in obstructive sleep apnea syndrome. Sleep Breath 14:241–244CrossRefPubMed Cifçi N, Uyar M, Elbek O et al (2010) Impact of CPAP treatment on cardiac biomarkers and pro-BNP in obstructive sleep apnea syndrome. Sleep Breath 14:241–244CrossRefPubMed
Metadaten
Titel
Obstructive sleep apnea and the effect of CPAP treatment on ischemia-modified albumin levels: a multi effect size meta-analysis with diagnostic test accuracy
verfasst von
Seshadri Reddy Varikasuvu
Naveen Dutt
Dibakar Sahu
Publikationsdatum
14.06.2018
Verlag
Springer International Publishing
Erschienen in
Sleep and Breathing / Ausgabe 1/2019
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-018-1679-6

Weitere Artikel der Ausgabe 1/2019

Sleep and Breathing 1/2019 Zur Ausgabe

Sleep Breathing Physiology and Disorders • Original Article

Bioinformatics analysis to reveal the key genes related to obstructive sleep apnea

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.